Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05967507 · ClinicalTrials.gov registry record · NA
Laryngoscopy for Neonatal and Infant Airway Management wIth Supplemental Oxygen at Different Flow Rates (OPTIMISE-2)
A NA study, sponsored by Thomas Riva.
- Recruiting
- Registry status
- NA
- Development phase
- 1,192
- Enrollment target
NCT05967507 is a NA study that is actively recruiting participants, run by Thomas Riva. The registered enrollment target is 1,192 participants.
The verdict
NCT05967507, a NA study, is actively recruiting participants, sponsored by Thomas Riva.
- RECRUITING
- Registry status
- NA
- Development phase
- 1,192 participants
- Enrollment target
Study Summary
This study aims to investigate the optimal oxygen flow rate needed during tracheal intubation with the C-MAC video laryngoscope (Karl Storz, Tuttlingen, Germany) using Miller-blade or Macintosh-blade size No. 0 or No. 1 in the operating room or intensive care unit. The investigators hypothesize that the difference between low-flow and high-flow supplemental oxygen is negligible.
Interventions
- DEVICE Low-flow nasal supplemental oxygen with a conventional nasal cannula during tracheal intubation with the C-MAC video laryngoscope
- DEVICE High-flow nasal supplemental oxygen (Fisher & Paykel, Auckland, New Zealand) during tracheal intubation with the C-MAC video laryngoscope
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1,192 participants |
| Start Date | 2023-12-01 |
| Est. Completion | 2027-09 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05967507
The ClinicalTrials.gov registry entry for NCT05967507 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 1,192 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Thomas Riva, which has 2 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Low-flow nasal supplemental oxygen with a conventional nasal cannula during tracheal intubation with the C-MAC video laryngoscope is the first listed.
NCT05967507 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT05967507 about?
NCT05967507 is a clinical study titled "Laryngoscopy for Neonatal and Infant Airway Management wIth Supplemental Oxygen at Different Flow Rates (OPTIMISE-2)". This study aims to investigate the optimal oxygen flow rate needed during tracheal intubation with the C-MAC video laryngoscope (Karl Storz, Tuttlingen, Germany) using Miller-blade or Macintosh-blade size No. 0 or No. 1 in the operating room or intensive care unit. The investigators hypothesize that...
What is the current status of trial NCT05967507?
This trial is currently recruiting. It is a NA study. The enrollment target is 1,192 participants. The study started on 2023-12-01. Estimated completion is 2027-09.
What interventions are being tested in trial NCT05967507?
The interventions under investigation include: Low-flow nasal supplemental oxygen with a conventional nasal cannula during tracheal intubation with the C-MAC video laryngoscope (DEVICE), High-flow nasal supplemental oxygen (Fisher & Paykel, Auckland, New Zealand) during tracheal intubation with the C-MAC video laryngoscope (DEVICE).
Who is sponsoring clinical trial NCT05967507?
This trial is sponsored by Thomas Riva, which has 2 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.